Insider · CIK 0001387877
Henry Brem
Files at GALT (GALECTIN THERAPEUTICS INC). First filing -, latest -.
Henry Brem files SEC Form 4 as director at GALT (GALECTIN THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Henry Brem has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Mar 17, 2026 |
Questions about Henry Brem
Answered from the filings on this page, as of the latest one.
Is Henry Brem buying or selling?
Henry Brem has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Henry Brem's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Henry Brem has 0.
Where does Henry Brem file Form 4?
Henry Brem has filed Form 4 at GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.